NTRA241220C125000
- 42.00
- 0.000.00%
Natera Newsroom
Natera Announces Its Prospera Lung Test Has Met Coverage Requirements From The Centers For Medicare & Medicaid Services' Molecular Diagnostics Services Program For Single Lung Transplant Recipients; This Coverage Applies To SLT Patients In The...
Express News | Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant Recipients
Piper Sandler Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $200
Piper Sandler Sticks to Their Buy Rating for Natera (NTRA)
Trade Alert: Independent Director Of Natera Gail Marcus Has Sold Stock
Guardant Health Says Jury Unanimously Rejected All Of Natera's Counterclaims And Awarded $292.5M To Company, Including $175.5M In Punitive Damages
Guardant Health Shares Are Trading Higher After a Jury Issued a Decision in the Company's Favor Regarding a False Advertising Case Filed by Natera Concerning Statements Made About Guardant's Reveal Test.
Natera Issues Statement On Guardant Health Litigation; Says "A Jury Issued A Decision In Guardant's Favor. We Disagree With This Decision And Will Ask The Court To Overturn It"
Express News | Natera Inc - to Ask Court to Overturn Jury Decision in Guardant Case
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
Natera to Present New SignateraTM Data in Multiple Abstracts at the San Antonio Breast Cancer Symposium
Natera Issues Statement on Guardant Health Litigation
Natera Co-Founder and Executive Chairman Matthew Rabinowitz Named 2024 R&D Leader of the Year
This week's hot stock in the US stock market | Is bitcoin competing for the 0.1 million mark? Major holders of MSTR coins have surged more than 5 times this year; the "AI faith" is once again causing a frenzy! Cloud storage giant snowflake soared 36% this
This week, the dow jones industrial average rose by 0.98%, closing at 43,870.35 points; during the same period, the s&p 500 index increased by 1.33%, closing at 5,948.71 points; the nasdaq index increased by 1.56%, closing at 18,972.42 points.
United States Non-Invasive Prenatal Testing Market Report 2025-2033: Illumina, Roche, and Natera, Which Have Established Themselves as Leaders Through Robust Research and Development
Natera Announces Publication of Over 100 Peer-Reviewed Papers on SignateraTM
U.S. Stock Market Nuggets | Will the "cryptos czar" appear? MSTR's market cap surpasses the trillion-dollar mark, soaring 650% this year; excellent stocks are having a blast! Home retail giant WSM skyrockets over 27% overnight.
Included in the S&P MidCap 400 Index! Global manufacturing giant Flex Ltd. surged nearly 80% this year, with overnight stock prices hitting a new high.
Goldman's Hedge Fund VIP List: AMZN, VST, CRM, BABA, and More
Trump Media Saw the Largest Increase in Short Interest in October
UBS Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $209